Comparison between Paytm IPO and Tatva Chintan Pharma Chem IPO.
Paytm IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tatva Chintan Pharma Chem IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Paytm IPO is up to ₹18,300.00 Cr whereas the issue size of the Tatva Chintan Pharma Chem IPO is up to ₹500.00 Cr. The final issue price of Paytm IPO is ₹2,150.00 per share and of Tatva Chintan Pharma Chem IPO is ₹1,083.00 per share.
| Paytm IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹2,080.00 per share | ₹1,073.00 per share |
| Issue Price (Upper) | ₹2,150.00 per share | ₹1,083.00 per share |
| Issue Price (Final) | ₹2,150.00 per share | ₹1,083.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 6 shares | 13 shares |
| Fresh Issue Size | 3,86,04,651 shares | 20,77,562 shares |
| Fresh Issue Size (Amount) | up to ₹8,300.00 Cr | up to ₹225.00 Cr |
| OFS Issue Size | 4,65,11,627 shares | 25,39,242 shares |
| OFS Issue Size (Amount) | up to ₹10,000.00 Cr | up to ₹275.00 Cr |
| Issue Size Total | 8,51,16,278 shares | 46,16,804 shares |
| Issue Size Total (Amount) | up to ₹18,300.00 Cr | up to ₹500.00 Cr |
Paytm IPO opens on Nov 08, 2021, while Tatva Chintan Pharma Chem IPO opens on Jul 16, 2021. The closing date of Paytm IPO and Tatva Chintan Pharma Chem IPO is Nov 10, 2021, and Jul 20, 2021, respectively.
| Paytm IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Anchor Bid Date | Nov 03, 2021 | Jul 15, 2021 |
| Issue Open | Nov 08, 2021 | Jul 16, 2021 |
| Issue Close | Nov 10, 2021 | Jul 20, 2021 |
| Basis Of Allotment (Tentative) | Nov 15, 2021 | Jul 26, 2021 |
| Initiation of Refunds (Tentative) | Nov 16, 2021 | Jul 27, 2021 |
| Credit of Share (Tentative) | Nov 17, 2021 | Jul 28, 2021 |
| Listing date (Tentative) | Nov 18, 2021 | Jul 29, 2021 |
| Anchor Lockin End date 1 | Dec 15, 2021 | Aug 25, 2021 |
| Anchor Lockin End date 2 | Feb 13, 2022 | Oct 24, 2021 |
Paytm IPO P/E ratio is , as compared to Tatva Chintan Pharma Chem IPO P/E ratio of .
| Paytm IPO | Tatva Chintan Pharma Chem IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | |||||
| Promoter Shareholding (Post-Issue) | 79.17 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹139378.84 Cr. | ₹2400.48 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Paytm IPO Retail Individual Investors (RII) are offered 85,11,627 shares while in Tatva Chintan Pharma Chem IPO retail investors are offered 85,11,627 shares. Qualified Institutional Buyers (QIB) are offered 2,55,34,884 shares in Paytm IPO and 9,23,361 shares in Tatva Chintan Pharma Chem IPO.
| Paytm IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,83,02,326 shares | 13,85,040 shares |
| Market Maker Reservation | ||
| QIB | 2,55,34,884 shares | 9,23,361 shares |
| NII | 1,27,67,441 shares | 6,92,521 shares |
| RII | 85,11,627 shares | 16,15,882 shares |
| Employee | ||
| Others | ||
| Total | 8,51,16,278 shares | 46,16,804 shares |
Paytm IPO subscribed 1.89x in total, whereas Tatva Chintan Pharma Chem IPO subscribed 180.36x.
| Paytm IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| QIB (times) | 2.79x | 185.23x |
| NII (times) | 0.24x | 512.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.66x | 35.35x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.89x | 180.36x |
